Literature DB >> 2544676

Serological typing scheme for BK-like isolates of human polyomavirus.

W A Knowles1, P E Gibson, S D Gardner.   

Abstract

Human polyomavirus BK-like isolates were subjected to restriction endonuclease analysis with the enzymes EcoRI and Hind III. End-point dilution was used to obtain homogeneous virus pools for DNA analysis and to remove JC virus from a mixed stock. The results of Hind III digestion suggested that two subgroups could be distinguished. Several BK-like isolates were purified and rabbit antisera raised. The isolates were compared with each other and with BK and JC viruses by haemagglutination-inhibition (HI) and by neutralisation. JC virus was serologically distinct, but all the other isolates showed some cross-reactivity. Two subgroups were again evident: GS and PG were with prototype BK in subgroup 1, and MG and IV were in subgroup 2. Two isolates, AS and SB, reacted with isolates of both subgroups 1 and 2 but were distinct from one another: their genome was similar to subgroup 1 isolates. Typing by HI or by neutralisation may form a basis for grouping BK-like polyomavirus isolates.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2544676     DOI: 10.1002/jmv.1890280212

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  26 in total

Review 1.  BK polyomavirus: emerging pathogen.

Authors:  Shauna M Bennett; Nicole M Broekema; Michael J Imperiale
Journal:  Microbes Infect       Date:  2012-02-24       Impact factor: 2.700

2.  Phylogenetic analysis of polyomavirus BK sequences.

Authors:  Preety M Sharma; Gaurav Gupta; Abhay Vats; Ron Shapiro; Parmjeet Randhawa
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

3.  Merkel cell polyomavirus and two previously unknown polyomaviruses are chronically shed from human skin.

Authors:  Rachel M Schowalter; Diana V Pastrana; Katherine A Pumphrey; Adam L Moyer; Christopher B Buck
Journal:  Cell Host Microbe       Date:  2010-06-25       Impact factor: 21.023

Review 4.  The role of sialic acid in human polyomavirus infections.

Authors:  Gretchen V Gee; Aisling S Dugan; Natia Tsomaia; Dale F Mierke; Walter J Atwood
Journal:  Glycoconj J       Date:  2006-02       Impact factor: 2.916

5.  Genotyping of polyomavirus BK by Real Time PCR for VP1 gene.

Authors:  Stefano Gambarino; Cristina Costa; Sara Astegiano; Elsa Alessio Piasentin; Giuseppe P Segoloni; Rossana Cavallo; Massimiliano Bergallo
Journal:  Mol Biotechnol       Date:  2011-10       Impact factor: 2.695

6.  Generation of Merkel cell polyomavirus (MCV)-like particles and their application to detection of MCV antibodies.

Authors:  Antoine Touzé; Julien Gaitan; Françoise Arnold; Raphaël Cazal; Maxime J Fleury; Nicolas Combelas; Pierre-Yves Sizaret; Serge Guyetant; Annabel Maruani; Marc Baay; Mauro Tognon; Pierre Coursaget
Journal:  J Clin Microbiol       Date:  2010-02-24       Impact factor: 5.948

7.  Marked variability of BK virus load measurement using quantitative real-time PCR among commonly used assays.

Authors:  Noah G Hoffman; Linda Cook; Ederlyn E Atienza; Ajit P Limaye; Keith R Jerome
Journal:  J Clin Microbiol       Date:  2008-06-18       Impact factor: 5.948

8.  Mutations in the external loops of BK virus VP1 and urine viral load in renal transplant recipients.

Authors:  Sara Tremolada; Serena Delbue; Lorenzo Castagnoli; Sara Allegrini; Umberto Miglio; Renzo Boldorini; Francesca Elia; Jennifer Gordon; Pasquale Ferrante
Journal:  J Cell Physiol       Date:  2010-01       Impact factor: 6.384

9.  BK virus and a new type of JC virus excreted by HIV-1 positive patients in rural Tanzania.

Authors:  H T Agostini; G R Brubaker; J Shao; A Levin; C F Ryschkewitsch; W A Blattner; G L Stoner
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

10.  Genotyping schemes for polyomavirus BK, using gene-specific phylogenetic trees and single nucleotide polymorphism analysis.

Authors:  Chunqing Luo; Marta Bueno; Jeffrey Kant; Jeremy Martinson; Parmjeet Randhawa
Journal:  J Virol       Date:  2008-12-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.